Subcutaneous pertuzumab-trastuzumab: Efficiency, safety, and the biosimilar horizon [0.03%]
皮下注射派ouselix-z妥昔单抗：疗效、安全性和生物类似药的前景
Asim Armagan Aydin,Erkan Kayikcioglu
Asim Armagan Aydin
Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands [0.03%]
荷兰双侧预防性乳腺切除术适应症研究——专家意见调查
L P Jansen,G M Kramer,E G Engelhardt et al.
L P Jansen et al.
Health-related quality of life and fear of recurrence after early breast cancer treatment: Results from a cross-sectional survey [0.03%]
一项横断面调查的结果：早期乳腺癌治疗后的生命质量及复发恐惧感
Paola Mosconi,Secondo Folli,Rosalba Miceli et al.
Paola Mosconi et al.
Background: The growing population of breast cancer survivors has raised attention to the long-term effects of treatment and follow-up. This study explored how survivors experience follow-up care and its impact on quality...
A UK study of the experiences, information needs and attitudes to clinical research among patients living with secondary breast cancer in the UK: A prospective co-developed study [0.03%]
英国继发性乳腺癌患者临床研究经历、信息需求和态度的研究：一项前瞻性共开发研究
Lesley Stephen,Janet Dunn,Claire Balmer et al.
Lesley Stephen et al.
Background: Clinical research is key to improving the outcomes of patients with metastatic breast cancer (MBC). However, participation is low, with little data on patients' attitudes and experiences of clinical research. ...
The Breast International Group (BIG) Patient Partnership: Embedding meaningful patient involvement in the design and conduct of breast cancer clinical research [0.03%]
乳腺国际组织(BIG)患者参与项目：在乳腺癌临床研究的设计和实施中嵌入有意义的患者参与
Carmela Caballero,Virginie Adam,Orsolya Birta et al.
Carmela Caballero et al.
Involving those with a lived experience of the relevant condition in the design of clinical research ensures that studies address real-world needs and priorities, enabling more relevant, ethical, and impactful outcomes. In 2019, the Breast ...
Impact of treatment response to neoadjuvant chemotherapy on brain metastasis patterns and breast cancer prognosis [0.03%]
新辅助化疗的治疗反应对脑转移模式和乳腺癌预后的影响
Jihwan Yoo,Yoon Jin Cha,Sung Gwe Ahn et al.
Jihwan Yoo et al.
Background: Brain metastases (BM) are a major cause of mortality in breast cancer. While pathologic complete response (pCR) after neoadjuvant chemotherapy is associated with favorable survival outcomes, its impact on BM d...
Early Ki67 change predicts prognosis and supports response-adapted therapy in breast cancer treated with neoadjuvant chemotherapy [0.03%]
新辅助化疗后早期Ki67变化可预测乳腺癌预后并指导个体化治疗
Ying Zhang,Siyu Wu,Liang Xue et al.
Ying Zhang et al.
Background: Early prediction of response to neoadjuvant chemotherapy (NACT) in breast cancer is critical for optimizing treatment strategies and improving outcomes. This study assessed the prognostic value of early Ki67 c...
Corrigendum to "Climate change impacts and sustainability integration among breast international group members" [The Breast Volume 81 June 2025 104469] [0.03%]
“乳腺国际组成员的气候变化影响和可持续性整合”一文的勘误(第81卷，2025年6月，104469)
Seamus O&#x;Reilly,Jessica Griffiths,Lisa Fox et al.
Seamus O&#x;Reilly et al.
Published Erratum
Breast (Edinburgh, Scotland). 2025 Nov 17:104653. DOI:10.1016/j.breast.2025.104653 2025
Breaking down the costs for breast cancer: Insights from Sweden's national quality register [0.03%]
瑞典国家质量登记处的乳腺癌成本分析见解
Xiaoyang Du,Leo Gkekos,Balram Rai et al.
Xiaoyang Du et al.
Background: With new emerging technologies for diagnostics and treatment for breast cancer, there is a demand for updated breast cancer costs based on current clinical practice. The objectives of this study were to estima...
Seamus O&#x;Reilly,Hans Wildiers,Alexandra Thomas
Seamus O&#x;Reilly